GenomSys
PrivateLast Round
VC Round
Apr 8, 2022
Total Funding Raised
$9.3M
Company Overview
GenomSys operates in Healthcare & Life Sciences and is based in Lausanne. Its latest recorded funding round was a VC Round in April 2022.
GenomSys is a health software company that provides an open-standard platform for the storage, processing, and analysis of genomic data based on the ISO/IEC 23092 MPEG-G standard.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenomSys Comparables
Compare GenomSys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Saphetor | 84% | |
| Limbus Medical Technologies GmbH | 83% | |
| SeqOne | 80% |
For institutional investors. Book with your work email.
GenomSys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Apr 8, 2022 | ||||
| Series A | Sep 18, 2019 | ||||
| Grant | Mar 19, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
GenomSys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Elysia Capital | Series A |
| Dolby Family Ventures | Series A |
| Preon Capital Partners | Series A |
| Eurostars SME programme | Grant |
| Club degli Investitori | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 19, 2026
Monthly visitors grew 110% MoM.
- May 11, 2026
Monthly visitors grew 403% MoM, from 393 to 2K.
For institutional investors. Book with your work email.
GenomSys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about GenomSys's valuation, stock price, and market status.
Is GenomSys a public or private company?
GenomSys is a private company.
What is the current stock price of GenomSys?
GenomSys is a private company, so its shares have no public market price. Caplight tracks GenomSys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is GenomSys worth (valuation)?
Valuation information for GenomSys is not publicly available.
Can I buy GenomSys stock?
GenomSys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was GenomSys's last funding round?
GenomSys's most recent funding round was VC Round on April 8, 2022.
Who are the main investors in GenomSys?
Key investors in GenomSys include Preon Capital Partners.
Will GenomSys IPO soon?
No public IPO plans have been announced for GenomSys.
How can I track GenomSys secondary market activity?
Caplight tracks bids, offers, and trades in GenomSys's shares on secondary markets.